Adimmune (TPE:4142) Total Liabilities: NT$3,141 Mil (As of Dec. 2025)


TPE:4142 Adimmune Corp TPE:4142
54 GF Score
Price NT$17.80
GF Value NT$25.53
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Adimmune Total Liabilities?

Adimmune TPE:4142 +2.30% 54 Total Liabilities is NT$3,141 Mil as of Dec. 2025. GuruFocus rates TPE:4142 with a GF Score™ of 54/100 and a GF Value™ of NT$25.53 (Possible Value Trap). The stock has 6 warning signs investors should review.

Adimmune's Total Liabilities for the quarter that ended in Dec. 2025 was NT$3,141 Mil.

Adimmune's quarterly Total Liabilities increased from Jun. 2025 (NT$3,370.01 Mil) to Sep. 2025 (NT$3,527.45 Mil) but then declined from Sep. 2025 (NT$3,527.45 Mil) to Dec. 2025 (NT$3,140.92 Mil).

Adimmune's annual Total Liabilities declined from Dec. 2023 (NT$3,706.87 Mil) to Dec. 2024 (NT$2,919.76 Mil) but then increased from Dec. 2024 (NT$2,919.76 Mil) to Dec. 2025 (NT$3,140.92 Mil).

Adimmune Total Liabilities Historical Data

* Premium members only.

The historical data trend for Adimmune's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adimmune Total Liabilities Chart

Adimmune Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,577.55 2,603.71 3,706.87 2,919.76 3,140.92

Adimmune Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,919.76 3,029.81 3,370.01 3,527.45 3,140.92
TPE:4142
54GF Score
Adimmune Corp TPE:4142
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adimmune Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Adimmune's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1545.848+(1593.825+1.2470000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=3,141

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=8192.632-5051.712
=3,141

Adimmune's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1545.848+(1593.825+1.2470000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=3,141

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=8192.632-5051.712
=3,141

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of NT$3,141 Mil mean?
Adimmune (TPE:4142) has a Total Liabilities of NT$3,141 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Adimmune and its competitors.
Is Adimmune's Total Liabilities too high?
Adimmune's current Total Liabilities is NT$3,141 Mil. Overall, Adimmune has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Adimmune's Total Liabilities compare to VRTX and REGN?
Adimmune's Total Liabilities of NT$3,141 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Adimmune and its competitors. Adimmune's current Total Liabilities is NT$3,141 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adimmune stock overvalued right now?
Based on GuruFocus' analysis, Adimmune (TPE:4142) is currently considered Possible Value Trap. The stock's GF Value™ is NT$25.53, compared to a current price of NT$17.80 — trading 30.3% below its estimated fair value. The current Total Liabilities is NT$3,141 Mil. Adimmune's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Adimmune (TPE:4142), the current Total Liabilities is NT$3,141 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adimmune (TPE:4142) Overvalued in 2026?

Based on GuruFocus' analysis, Adimmune stock appears to be undervalued. The current stock price of NT$17.80 is trading 30.3% below its estimated GF Value™ of NT$25.53. GuruFocus considers Adimmune to be Possible Value Trap.

Key valuation signals for TPE:4142:

  • Total Liabilities: NT$3,141 Mil
  • GF Value™: NT$25.53 vs. price of NT$17.80 (30.3% below fair value)
  • GF Score™: 54/100 with 6 warning signs

No single metric tells the full story. See the TPE:4142 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adimmune Business Description

Address Tanxing Road, No. 3, Section 1, Tanzi District, Taichung City, TWN, 427003
Adimmune Corp is engaged in the research and development, processing, manufacturing, and trading of serum, vaccines, testing reagents, biologicals, and other bacterial fluids, as well as western medicines, animal medicines, chemicals, and feed additives. Its segments are separated by business as Adimmune Corporation, which generates maximum revenue and is engaged in the manufacturing of influenza vaccines with EU GMP and US FDA certificates in Taiwan. Its products include Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine, Influenza A (H1N1) Virus Monovalent Vaccine, and others, and Enimmune Corporation. The Group's revenue is mainly from the manufacturing and trading of vaccines, modern medicine products and testing reagents, as well as entrusted packing of vaccines.
54GF Score

Get the complete analysis for TPE:4142

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$17.80
Price
NT$25.53
GF Value